Companies: 10,795·Total market cap: $144.5T
Asensus Surgical, Inc.

Asensus Surgical, Inc.

ASXCAMEXHealthcare
$0.35
+$0.00(+0.64%)
Market Cap$94922082
P/E Ratio
52W High$0.3993
52W Low$0.169

Asensus Surgical, Inc.(ASXC)股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

asxc · 股价预测 · 2 位分析师(近3月)· FMP · 更新于 2025年4月25日

分析师评级与共识

基于过去 3 个月内 2 位华尔街分析师

SellBuy

Hold

2 位分析师

共识

评级分布

Strong Buy
0
Buy
0
Hold
2
Sell
0
Strong Sell
0
合计: 2 · 买入占比: 0.0%

12 个月目标价

High

$1.50

Consensus

$1.50

+331.2% upside

Low

$1.50

Median: $1.5 · Last Close: $0.35

Asensus Surgical, Inc.(ASXC)的分析师共识为 Hold,基于过去 3 个月内 2 位华尔街分析师的评级。ASXC 的 12 个月平均目标价为 $1.50,相对当前价 $0.35 代表 +331.2% 的潜在上行空间。

12 个月目标价预测

历史收盘价 + 分析师 12 个月目标价预测区间

分析师目标价覆盖不足,无法为该股票生成预测图表。

短期股价预测

算法生成 · 每日更新

DatePredicted PriceChange
2026-06-09$0.341.37%

1-day model range: $0.34–$0.35. Peak: $0.35 (-1.37%).

长期股价预测

⚠️ 在满 252 个交易日历史(IPO/上市时间较短)前不展示长期预测;短期标签页仍可能显示模型输出。

基于技术分析的股价预测

14 项技术面信号(SMA×6 + EMA×6 + RSI + MACD)· EEAT 方法论透明

Market Sentiment

BULLISH

Based on 14 technical indicators

57%36%7%
8Buy
5Neutral
1Sell
RSI (14)56.1Neutral
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · ASXC · Jun 9, 2026

Simple Moving Average (SMA)
MA 5$0.31BUY
MA 10$0.31BUY
MA 20$0.32BUY
MA 50$0.33BUY
MA 100$0.00NEUTRAL
MA 200$0.00NEUTRAL
Current $ASXC · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$0.33BUY
EMA 10$0.32BUY
EMA 20$0.32BUY
EMA 50$0.33BUY
EMA 100$0.00NEUTRAL
EMA 200$0.00NEUTRAL
Current $ASXC · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:
HC Wainwright & Co.2024-05-16
Maintains
NeutralNeutral
HC Wainwright & Co.2024-04-04
Downgrade ↓
BuyNeutral
HC Wainwright & Co.2024-03-22
Maintains
BuyBuy
Cantor Fitzgerald2023-11-16
Downgrade ↓
OverweightNeutral
HC Wainwright & Co.2023-11-15
Maintains
BuyBuy
Cantor Fitzgerald2023-08-22
Maintains
OverweightOverweight
Cantor Fitzgerald2023-08-21
Maintains
OverweightOverweight
HC Wainwright & Co.2023-08-11
Maintains
BuyBuy
HC Wainwright & Co.2023-08-10
Maintains
BuyBuy
HC Wainwright & Co.2023-05-12
Maintains
BuyBuy

Wall Street analysts have recently issued updated ratings on Asensus Surgical, Inc. (ASXC) stock. Of the recent 19 rating actions, 0 were upgrades and 2 were downgrades. 2 analysts currently cover ASXC.

分析师推荐趋势

Buy ratings202
Hold ratings01↑ +1
Sell ratings00

ASXC analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 0 per month.

财务预测:EPS 与营收一致预期

Revenue This Year

$12M

↓ 76.5% YoY

Revenue Next Year

$22M

↑ 81.7% YoY

EPS This Year

$-0.24

EPS Next Year

$-0.19

↓ 20.8% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast ASXC EPS of $-0.24 for the current fiscal year, based on estimates from 1 analysts. The ASXC revenue forecast is $12M for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

ASXC 股价预测由两类独立数据源支撑:来自 2 位华尔街分析师(S&P Global / FMP)的共识评级,以及基于历史日终价计算的技术分析。ASXC 的共识目标价为 $1.50(+331.2% 上行空间),分析师共识为 Hold。

ASXC 的短期预测(明日)为 $0.34(-1.37%)。

Asensus Surgical, Inc. 在 AMEX 上市,代码 ASXC。ASXC 在 2027 年的整体展望偏中性/分化,在覆盖分析师中约 0% 对应 Hold 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

常见问题

ASXC 预测 · 8 个问题

根据 2 位华尔街分析师,ASXC 的 12 个月平均目标价为 $1.50,最高 $1.50、最低 $1.50。若有图表,中位目标价可在上方查看。相对当前价 $0.35,隐含约 +331.2% 的上行空间。

ASXC 目标价ASXC 分析师目标价ASXC 12个月目标价目标价 ASXC

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.